February 22, 2012 2:57 PM
Who said this panel vote would be close? Non-agency experts gave strong support to Vivus' ($VVUS) quest to gain FDA approval for its diet pill Qnexa, voting 20-2 this afternoon to support the drug getting a green light to hit the U.S. market, TheStreet reported. The Endocrinologic and Metabol...
read more >
February 22, 2012 9:59 AM
Tokyo's Anaeropharma Science is launching U.S. clinical trials as early as March for a new stomach cancer drug fueled by bacteria. The biotech is partnering with Japanese drug giant Eisai to bring the treatment to market, according to the Daily Yomiuri. Testing will involve 60 patients over 3 &fra...
read more >
February 22, 2012 9:53 AM
With drug delivery tech from a children's hospital in Philadelphia, Vascular Magnetics has pocketed a $7 million Series A round from lone investor Devon Park Bioventures. And the startup has ambitious plans to advance magnetic drug-loaded particles for the huge market to treat peripheral artery disease...
read more >
February 22, 2012 4:04 AM
Warnex has pulled out of a C$1.1m (€833,000) deal to sell its analytical services business, alleging that the buyer failed to fulfil its obligations.
read more >
February 22, 2012 5:11 AM
Frontage Laboratories says it is focussing on improving regulatory and GMP compliance in China after signing a $10m (€7.5m) collaboration with drugs maker Fanghui Pharma.
read more >
February 22, 2012 4:11 AM
Draft EU GDP guidelines would “significantly increase” supply-chain costs and be “virtually impossible” to carry out, big pharma and logistics companies said.
read more >
Xencor and Boehringer Ingelheim have entered into an agreement to develop, manufacture and supply certain Xencor biosuperior monoclonal antibodies.
read more >
ProactiveLife, a provider of natural supplements, has launched new Diabetes Support supplement for people with Type 2 Diabetes and Pre-Diabetes.
read more >
OphthaliX has received patent, entitled Adenosine A3 receptor agonists for the treatment of dry eye disorders, from Chinese State Intellectual Property Office (SIPO).
read more >